Cora has been struggling with the onset of early dementia. She is having a very hard time remembering her address, her grandchildren's names, and her daily routine. Cora was accepted into a clinical trial for a new drug to test its effectiveness compared with other medications on the market in slowing down the symptoms of dementia. Cora, without her knowledge, was placed in the placebo group and many of the other participants were randomly selected for placement in five different medication groups. Cora was initially assessed; she was given a sugar pill for the next 6 months with periodic neurocognitive assessments to monitor any change. Cora was part of which type of research design?
A) mixed factorial design
B) between-subjects design
C) within-subjects design
D) quasi-experimental design

Question

Quizplus · Accepted Answer

Cora's participation in a clinical trial where she was placed in a placebo group, while other participants were placed in different medication groups, without receiving multiple treatments herself, indicates a between-subjects design. This design involves comparing different groups of participants, each group receiving a different treatment or condition.

Cora Has Been Struggling with the Onset of Early Dementia